What the research examined
Two mouse studies examined AOD-9604 and metabolic measurements such as fat oxidation and body-weight change. One used animals lacking the beta-3 adrenergic receptor to investigate the receptor's contribution. The authors distinguished changes in receptor expression from a simple claim of direct receptor-mediated action.
How to interpret the findings
The findings are specific to experimental mouse models. They do not demonstrate human weight-loss efficacy. Receptor-knockout experiments also require careful interpretation because deleting a receptor can affect several physiological processes.
Research literature
- The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice.
Endocrinology · 2001 · PMID 11713213 - Increase of fat oxidation and weight loss in obese mice caused by chronic treatment with human growth hormone or a modified C-terminal fragment.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity · 2001 · PMID 11673763
Links open the indexed paper records. Summaries are based on those records and their available abstracts, not a systematic review or a full-text appraisal of every study.